Omic approaches to quality biomarkers for stored platelets: Are we there yet?

Transfusion Medicine Reviews

Volumn 24, Issue 3, 2010, Pages 211-217

  Kulkarni, Sandhya ^a   Kannan, Meganathan ^a   Atreya, Chintamani D ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA;

ARTICLE; BIOCHEMISTRY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR BIOLOGY; PROTEOMICS; QUALITY CONTROL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE STRUCTURE; THROMBOCYTE TRANSFUSION; TRANSCRIPTOMICS; BLOOD STORAGE; CYTOLOGY; GENOMICS; PROCEDURES;

BIOLOGICAL MARKERS; BLOOD PLATELETS; BLOOD PRESERVATION; GENOMICS; HUMANS; PROTEOMICS;

EID: 77955106042     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2010.03.003     Document Type: Article

References (50)

1. Connor J., Currie L.M., Allan H., et al. Recovery of in vitro functional activity of platelet concentrates stored at 4 degrees C and treated with second-messenger effectors. Transfusion 1996, 36:691-698.
2. Lozano M., Escolar G., Mazzara R., et al. Effects of the addition of second-messenger effectors to platelet concentrates separated from whole-blood donations and stored at 4 degrees C or -80 degrees C. Transfusion 2000, 40:527-534.
3. Gulliksson H., AuBuchon J.P., Vesterinen M., et al. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Storage of platelets in additive solutions: A pilot in vitro study of the effects of potassium and magnesium. Vox Sang 2002, 82:131-136.
4. Ringwald J., Walz S., Zimmermann R., et al. Hyper-concentrated platelets stored in additive solution: Aspects on productivity and in vitro quality. Vox Sang 2005, 89:11-18.
5. Ringwald J., Zimmermann R., Eckstein R. The new generation of platelet additive solution for storage at 22 degrees C: Development and current experience. Transfus Med Rev 2006, 20:158-164.
6. van der Meer P.F., Liefting L.A., Pietersz R.N. The effect of interruption of agitation on in vitro measures of platelet concentrates in additive solution. Transfusion 2007, 47:955-959.
7. Sandgren P., Hansson M., Gulliksson H., et al. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: Flow cytometry analysis of platelet glycoprotein expression. Vox Sang 2007, 93:27-36.
8. Zhang J.G., Carter C.J., Devine D.V., et al. Comparison of a novel viscous platelet additive solution and plasma: Preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates. Vox Sang 2008, 94:299-305.
9. Hornsey V.S., McColl K., Drummond O., et al. Extended storage of platelets in SSP platelet additive solution. Vox Sang 2006, 91:41-46.
10. Hornsey V.S., Drummond O., McMillan L., et al. Cold storage of pooled, buffy-coat-derived, leucoreduced platelets in plasma. Vox Sang 2008, 95:26-32.
11. Hirayama J., Azuma H., Fujihara M., et al. Storage of platelets in 30 percent plasma and 70 percent M-sol additive solution. Transfusion 2008, 48:567-568.
12. Cardigan R., Sutherland J., Garwood M., et al. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags. Vox Sang 2008, 94:103-112.
13. Rinder H.M., Snyder E.L., Tracey J.B., et al. Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: Restoration of secretory function and maintenance of platelet survival. Transfusion 2003, 43:1230-1237.
14. Bertolini F., Murphy S. A multicenter evaluation of reproducibility of swirling in platelet concentrates. Transfusion 1994, 34:796-801.
15. Fratantoni J.C., Poindexter B.J., Bonner R.F. Quantitative assessment of platelet morphology by light scattering: A potential method for the evaluation of platelets for transfusion. J Lab Clin Med 1984, 103:620-631.
16. Kunicki T.J., Tucelli M., Becker G.A., et al. A study of variables affecting the quality of platelets stored at room temperature. Transfusion 1975, 15:414-421.
17. White J.G. Ultrastructural physiology and cytochemistry of blood platelets. The platelet 1971, 83. Baltimore: Williams & Wilkins. K.M. Brinkhous, R.W. Shermer, F.K. Mostofi (Eds.).
18. Murphy S., Rebulla P., Bertolini F., et al. In vitro assessment of the quality of stored platelet concentrates. Transfus Med Rev 1994, 8:29-36.
19. Murphy S., Kahn R.A., Holme S., et al. Improved storage of platelets for transfusion in a new container. Blood 1982, 60:194-200.
20. Holme S., Moroff G., Murphy S. A multi-laboratory evaluation of in vitro platelet assays: The tests for extent of shape change and response to hypotonic shock. Transfusion 1998, 38:31-40. for the Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion.
21. Shattil S.J., Cunnigham M., Hoxie J.A. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987, 70:307-315.
22. Holmsen H. Significance of testing platelet functions in vitro. Eur J Clin Invest 1994, 24:3-8.
23. Dachary-Prigent J., Toti F., Satta N., et al. Physiopathological significance of catalytic phospholipids in the generation of thrombin. Semin Thromb Hemost 1996, 22:157-164.
24. Lederberg J., McCray A.T. Ome sweet 'omics: A genealogical treasury of words. The Scientist 2001, 15:8-9.
25. Thiele T., Steil L., Gebhard S., et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007, 47:1221-1233.
26. García A. Two-dimensional gel electrophoresis in platelet proteomics research. Methods Mol Med 2007, 139:339-353.
27. Thon J.N., Schubert P., Duguay M., et al. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 2008, 48:425-435.
28. Bertino A.M., Qi X.Q., Li J., et al. Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion 2003, 43:857-866.
29. Bugert P., Dugrillon A., Günaydin A., et al. Messenger RNA profiling of human platelets by microarray hybridization. Thromb Haemost 2003, 90:738-748.
30. Weyrich A.S., Dixon D.A., Pabla R., et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A. 1998, 95:5556-5561.
31. Gnatenko D.V., Dunn J.J., McCorkle S.R., et al. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003, 101:2285-2293.
32. Kieffer N., Guichard J., Farcet J., et al. Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem 1987, 164:189-195.
33. Dittrich M., Birschmann I., Pfrang J., et al. Analysis of SAGE data in human platelets: Features of the transcriptome in an anucleate cell. Thromb Haemost 2006, 95:643-651.
34. Calin G.A., Dumitru C.D., Shimizu M., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002, 99:15524-15529.
35. García A., Prabhakar S., Hughan S., et al. Differential proteome analysis of TRAP-activated platelets: Involvement of DOK-2 and phosphorylation of RGS proteins. Blood 2004, 103:2088-2095.
36. Michael M.Z., O' Connor S.M., van Holst Pellekaan N.G., et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882-891.
37. Bartel D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
38. Lim L.P., Lau N.C., Garrett-Engele P., et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
39. Zhang B., Farwell M.A. MicroRNAs: A new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 2008, 12:3-21.
40. Medina P.P., Slack F.J. MicroRNAs and cancer: An overview. Cell Cycle 2008, 7:2485-2492.
41. Singh S.K., Pal Bhadra M., Girschick H.J., et al. MicroRNAs-Micro in size but macro in function. FEBS J 2008, 275:4929-4944.
42. Erson A., Petty E. MicroRNAs in development and disease. Clin Genet 2008, 74:296-306.
43. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105:10513-10518.
44. Schepeler T., Reinert J.T., Ostenfeld M.S., et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008, 68:6416-6424.
45. Wolf B.B., Goldstein J.C., Stennicke H.R., et al. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 1999, 94:1683-1692.
46. Li J., Xia Y., Bertino A.M., et al. The mechanism of apoptosis in human platelets during storage. Transfusion 2000, 40:1320-1329.
47. Weyrich A.S., Denis M.M., Schwertz H., et al. mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood 2007, 109:1975-1983.
48. Zimmerman G.A., Weyrich A.S. Signal-dependent protein synthesis by activated platelets: New pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol 2008, 28:17-24.
49. Landry P., Plante I., Ouellet D.L., et al. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009, 16:961-966.
50. Kannan M., Mohan K.V., Kulkarni S., et al. Membrane array-based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis. Transfusion 2009, 49:1443-1450.